Amplius Wealth Advisors’s MetLife MET Stock Holding History

Amplius Wealth Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-139	Closed	-$8K	–	608
2021 Q4	$8K	Buy	+139	New	+$8.72K	﹤0.01%	640

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Amplius Wealth Advisors's MET Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of MetLife (MET) in Q1 2022, closing a stake of 139 shares — an estimated $8K sold.

Amplius Wealth Advisors first reported a position in MET in Q4 2021 and held it in 1 quarter. The position peaked at $8K in Q4 2021. 1,222 funds tracked by Wall St. Rank hold MET as of Q1 2022.

Amplius Wealth Advisors reported no remaining MetLife position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 139 MetLife shares in Q1 2022, an estimated $8K.
Amplius Wealth Advisors first reported a position in MetLife in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's MetLife position peaked at $8K in Q4 2021.
1,222 funds tracked by Wall St. Rank held MetLife as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.